United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $831,715,183.10
- April 14, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 2, 2014 | Director | 3,000 | $111.41 | Sell | $334,230.00 | |
Jan. 2, 2014 | CEO | 3,833 | $111.54 | Sell | $427,532.82 | |
Dec. 31, 2013 | CEO | 18,140 | $112.64 | Sell | $2,043,289.60 | |
Dec. 30, 2013 | CEO | 18,147 | $111.60 | Sell | $2,025,205.20 | |
Dec. 27, 2013 | CEO | 18,147 | $113.15 | Sell | $2,053,333.05 | |
Dec. 26, 2013 | CEO | 21,981 | $111.95 | Sell | $2,460,772.95 | |
Dec. 24, 2013 | CEO | 18,149 | $114.05 | Sell | $2,069,893.45 | |
Dec. 23, 2013 | CEO | 5,743 | $109.71 | Sell | $630,064.53 | |
Dec. 20, 2013 | CEO | 18,149 | $86.72 | Sell | $1,573,881.28 | |
Dec. 20, 2013 | COO | 8,250 | $87.84 | Sell | $724,680.00 | |
Dec. 19, 2013 | EVP | 6,000 | $86.45 | Sell | $518,700.00 | |
Dec. 19, 2013 | CEO | 21,982 | $86.73 | Sell | $1,906,498.86 | |
Dec. 18, 2013 | CEO | 18,149 | $86.36 | Sell | $1,567,347.64 | |
Dec. 17, 2013 | CEO | 12,251 | $86.49 | Sell | $1,059,588.99 | |
Dec. 6, 2013 | COO | 10,000 | $90.97 | Sell | $909,700.00 | |
Dec. 5, 2013 | Director | 3,000 | $90.13 | Sell | $270,390.00 | |
Dec. 5, 2013 | EVP | 6,000 | $89.18 | Sell | $535,080.00 | |
Dec. 5, 2013 | CEO | 3,833 | $89.79 | Sell | $344,165.07 | |
Nov. 21, 2013 | CEO | 3,833 | $92.49 | Sell | $354,514.17 | |
Nov. 21, 2013 | EVP | 6,000 | $92.47 | Sell | $554,820.00 | |
Nov. 15, 2013 | COO | 10,000 | $94.00 | Sell | $940,000.00 | |
Nov. 14, 2013 | Director | 5,500 | $91.65 | Sell | $504,075.00 | |
Nov. 14, 2013 | CEO | 3,833 | $91.60 | Sell | $351,102.80 | |
Nov. 7, 2013 | EVP | 6,000 | $89.60 | Sell | $537,600.00 | |
Nov. 7, 2013 | CEO | 3,833 | $89.47 | Sell | $342,938.51 | |
Nov. 7, 2013 | Director | 3,500 | $90.51 | Sell | $316,785.00 | |
Nov. 1, 2013 | Director | 3,000 | $89.18 | Sell | $267,540.00 | |
Nov. 1, 2013 | COO | 10,000 | $90.34 | Sell | $903,400.00 | |
Oct. 31, 2013 | CEO | 3,833 | $86.89 | Sell | $333,049.37 | |
Oct. 24, 2013 | CEO | 3,833 | $83.77 | Sell | $321,090.41 | |
Oct. 18, 2013 | COO | 10,000 | $82.47 | Sell | $824,700.00 | |
Oct. 17, 2013 | EVP | 6,000 | $81.79 | Sell | $490,740.00 | |
Oct. 17, 2013 | CFO | 2,750 | $82.01 | Sell | $225,527.50 | |
Oct. 17, 2013 | CEO | 3,833 | $81.84 | Sell | $313,692.72 | |
Oct. 10, 2013 | CEO | 3,833 | $82.58 | Sell | $316,529.14 | |
Oct. 4, 2013 | COO | 10,000 | $85.48 | Sell | $854,800.00 | |
Oct. 3, 2013 | Director | 1,500 | $83.15 | Sell | $124,725.00 | |
Oct. 3, 2013 | CFO | 4,500 | $84.67 | Sell | $381,015.00 | |
Oct. 3, 2013 | CEO | 3,833 | $84.20 | Sell | $322,738.60 | |
Oct. 3, 2013 | EVP | 6,000 | $84.38 | Sell | $506,280.00 | |
Sept. 26, 2013 | CEO | 3,833 | $78.41 | Sell | $300,545.53 | |
Sept. 20, 2013 | COO | 10,000 | $77.86 | Sell | $778,600.00 | |
Sept. 19, 2013 | CFO | 4,500 | $78.67 | Sell | $354,015.00 | |
Sept. 19, 2013 | EVP | 6,000 | $78.02 | Sell | $468,120.00 | |
Sept. 19, 2013 | CEO | 3,833 | $78.12 | Sell | $299,433.96 | |
Sept. 12, 2013 | CEO | 3,833 | $76.98 | Sell | $295,064.34 | |
Sept. 6, 2013 | COO | 10,000 | $73.67 | Sell | $736,700.00 | |
Sept. 5, 2013 | CEO | 3,833 | $73.63 | Sell | $282,223.79 | |
Sept. 5, 2013 | EVP | 6,000 | $73.29 | Sell | $439,740.00 | |
Sept. 5, 2013 | CFO | 4,500 | $74.17 | Sell | $333,765.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 14, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.